Acute leukemias after treatment with radioiodine for thyroid cancer
- PMID: 9793274
Acute leukemias after treatment with radioiodine for thyroid cancer
Abstract
Leukemia is an uncommon complication of exposure to radioiodine (131I), used in treatment of thyroid cancer, because low doses are now used. We report two cases of acute myelogenous leukemia developed after the treatment of a thyroid carcinoma with a small dose of 131I.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical